Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment modalities for narcolepsy

J M Fry1

  • 1Department of Neurology, Allegheny University of Health Sciences, Philadelphia, PA 19129, USA.

Neurology
|March 4, 1998
PubMed
Summary
This summary is machine-generated.

Modafinil effectively treats narcolepsy by reducing daytime sleepiness. This wake-promoting agent showed significant improvements in sleepiness measures and was well-tolerated in a clinical trial.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conservatism in Gun-Shot Wounds of the Abdomen.

Texas medical journal (Austin, Tex.)·2023
Same author

Long-term follow-up on restless legs syndrome patients treated with opioids.

Movement disorders : official journal of the Movement Disorder Society·2001
Same author

Thermoregulatory, metabolic and sympathoadrenal responses to repeated brief exposure to cold.

Scandinavian journal of clinical and laboratory investigation·1999
Same author

Full polysomnography in the home.

Sleep·1998
Same author

The indications for polysomnography and related procedures.

Sleep·1997
Same author

Inspiratory fall in systolic pressure in normal and asthmatic subjects.

American journal of respiratory and critical care medicine·1995
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Sleep Medicine
  • Pharmacology

Background:

  • Narcolepsy is a chronic neurological disorder impacting wakefulness.
  • Current treatments like CNS stimulants have limitations and side effects.
  • There is a need for effective and well-tolerated narcolepsy therapies.

Purpose of the Study:

  • To evaluate the efficacy and safety of modafinil in treating narcolepsy.
  • To assess modafinil's impact on subjective and objective measures of sleepiness.

Main Methods:

  • A 9-week, randomized, placebo-controlled trial across 18 US centers.
  • Participants received either modafinil (200 mg or 400 mg daily) or a placebo.
  • Key outcome measures included the Epworth Sleepiness Scale, Maintenance of Wakefulness Test, and Multiple Sleep Latency Test.

Related Experiment Videos

Main Results:

  • Modafinil significantly reduced daytime sleepiness compared to placebo (p < 0.001).
  • Improvements were observed in objective sleepiness tests (MWT, MSLT) and subjective scales (ESS).
  • Modafinil was well-tolerated, with headache being the most frequent adverse event (p < 0.05).

Conclusions:

  • Modafinil is an effective and well-tolerated treatment for narcolepsy.
  • It offers a new therapeutic option for managing excessive daytime sleepiness.
  • The study supports modafinil's role in improving the quality of life for narcolepsy patients.